Cortistatin Levels in Diabetic Retinas
Author Information
Author(s): Carrasco Esther, Hernández Cristina, de Torres Inés, Farrés Jaume, Simó Rafael
Primary Institution: Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas asociadas (CIBERDEM)
Hypothesis
The study aims to explore whether the retina produces cortistatin (CST) and to compare its expression between diabetic and nondiabetic donors.
Conclusion
Cortistatin is expressed in the human retina, with lower levels found in diabetic retinas, which is associated with retinal neurodegeneration.
Supporting Evidence
- Cortistatin mRNA levels were significantly lower in diabetic donors compared to nondiabetic donors.
- Diabetic retinas showed increased levels of glial fibrillar acidic protein (GFAP) and higher apoptosis rates.
- An inverse correlation was found between cortistatin levels and the percentage of apoptotic cells.
Takeaway
This study found that a substance called cortistatin, which helps protect the retina, is lower in people with diabetes, and this might be linked to eye damage.
Methodology
The study compared human postmortem eyes from diabetic and nondiabetic donors, measuring cortistatin mRNA and protein levels, and assessing retinal neurodegeneration through specific markers.
Limitations
The study cannot confirm the normalcy of eye exams for nondiabetic donors prior to death.
Participant Demographics
Five diabetic donors (average age 64.5 years) and five nondiabetic donors (average age 66.2 years), matched by age and gender.
Statistical Information
P-Value
p=0.001 for RPE, p=0.03 for neuroretina
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website